Your search returned 8 results.

Results
	1.	Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283. [electronic resource] by Curry, Jayne Angove, Hayley Fazal, Lynsey Lyons, John Reule, Matthias Thompson, Neil Wallis, Nicola Producer: 20090814 In: Cell cycle (Georgetown, Tex.) vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway. [electronic resource] by Kasper, Grit Reule, Matthias Tschirschmann, Miriam Dankert, Niels Stout-Weider, Karen Lauster, Roland Schrock, Evelin Mennerich, Detlev Duda, Georg N Lehmann, Kerstin E Producer: 20070306 In: BMC cancer vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The heat shock protein 90 inhibitor, AT13387, displays a long duration of action in vitro and in vivo in non-small cell lung cancer. [electronic resource] by Graham, Brent Curry, Jayne Smyth, Tomoko Fazal, Lynsey Feltell, Ruth Harada, Isobel Coyle, Joe Williams, Brian Reule, Matthias Angove, Hayley Cross, David M Lyons, John Wallis, Nicola G Thompson, Neil T Producer: 20120416 In: Cancer science vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL-positive leukemic cells. [electronic resource] by Tanaka, Ruriko Squires, Matthew S Kimura, Shinya Yokota, Asumi Nagao, Rina Yamauchi, Takahiro Takeuchi, Miki Yao, Hisayuki Reule, Matthias Smyth, Tomoko Lyons, John F Thompson, Neil T Ashihara, Eishi Ottmann, Oliver G Maekawa, Taira Producer: 20101027 In: Blood vol. 116 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. [electronic resource] by Grimshaw, Kyla M Hunter, Lisa-Jane K Yap, Timothy A Heaton, Simon P Walton, Mike I Woodhead, Steven J Fazal, Lynsey Reule, Matthias Davies, Thomas G Seavers, Lisa C Lock, Victoria Lyons, John F Thompson, Neil T Workman, Paul Garrett, Michelle D Producer: 20100820 In: Molecular cancer therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. [electronic resource] by Howard, Steven Berdini, Valerio Boulstridge, John A Carr, Maria G Cross, David M Curry, Jayne Devine, Lindsay A Early, Theresa R Fazal, Lynsey Gill, Adrian L Heathcote, Michelle Maman, Sarita Matthews, Julia E McMenamin, Rachel L Navarro, Eva F O'Brien, Michael A O'Reilly, Marc Rees, David C Reule, Matthias Tisi, Dominic Williams, Glyn Vinković, Mladen Wyatt, Paul G Producer: 20090223 In: Journal of medicinal chemistry vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design. [electronic resource] by Wyatt, Paul G Woodhead, Andrew J Berdini, Valerio Boulstridge, John A Carr, Maria G Cross, David M Davis, Deborah J Devine, Lindsay A Early, Theresa R Feltell, Ruth E Lewis, E Jonathan McMenamin, Rachel L Navarro, Eva F O'Brien, Michael A O'Reilly, Marc Reule, Matthias Saxty, Gordon Seavers, Lisa C A Smith, Donna-Michelle Squires, Matt S Trewartha, Gary Walker, Margaret T Woolford, Alison J-A Producer: 20080910 In: Journal of medicinal chemistry vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity. [electronic resource] by Yap, Timothy A Walton, Mike I Grimshaw, Kyla M Te Poele, Robert H Eve, Paul D Valenti, Melanie R de Haven Brandon, Alexis K Martins, Vanessa Zetterlund, Anna Heaton, Simon P Heinzmann, Kathrin Jones, Paul S Feltell, Ruth E Reule, Matthias Woodhead, Steven J Davies, Thomas G Lyons, John F Raynaud, Florence I Eccles, Suzanne A Workman, Paul Thompson, Neil T Garrett, Michelle D Producer: 20130403 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)